COMMUNIQUÉS West-GlobeNewswire

Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency

28/02/2018 - 13:00

28 February 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty [...]

Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference

28/02/2018 - 13:00

THE WOODLANDS, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]

Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results

28/02/2018 - 13:00

CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for [...]

Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018

28/02/2018 - 13:00

NEW HAVEN, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates

28/02/2018 - 13:00

Galafold Expansion Continues with 360+ Fabry Patients Treated Today - on Track to Achieve FY18 Revenue Guidance of $75M-$85M Significant Progress Across Pompe Clinical, Regulatory and Manufacturing Activities - [...]

Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)

28/02/2018 - 13:00

RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

VitalHub Subsidiary HInext Adds 16 New Customers in New York State

28/02/2018 - 13:00

TORONTO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V: VHI ) is pleased to announce that its subsidiary HInext Inc. (“HInext”) has obtained 16 new customers in New York State, [...]

Axsome Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018

28/02/2018 - 13:00

NEW YORK, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Evogene Reports Fourth Quarter and Full Year 2017 Financial Results

28/02/2018 - 13:00

REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique Computational [...]

Novelion Therapeutics Observes Rare Disease Day

28/02/2018 - 13:00

VANCOUVER, British Columbia, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients

28/02/2018 - 13:00

STAMFORD, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update

28/02/2018 - 13:00

Key updates Runway into the second half of 2019: cash of €48.0 million at year-end expected to fund operations through anticipated clinical data readouts in three different programs. First patient dosed in the Phase 1/2 [...]

Akcea Therapeutics Recognizes Rare Disease Day by Spotlighting Several Historic “Firsts” for People Living with Familial Chylomicronemia Syndrome

28/02/2018 - 13:00

CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program

28/02/2018 - 12:45

GAITHERSBURG, Md., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced a contract award by the Centers for Disease Control and Prevention (CDC) valued at $26 million over 12 months [...]

Syneos Health Reports Fourth Quarter and Full Year 2017 Results

28/02/2018 - 12:38

Highlights Combined Company net new business awards of $622.9 million for the fourth quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined Company book-to-bill [...]

Achillion Raises Awareness for C3 Glomerulopathy With Launch of WeC3G™ Initiative as Part of Rare Disease Day 2018

28/02/2018 - 12:05

February 28, 2018 is the 11 th Annual Rare Disease Day Achillion sponsors initiative to help shine the light on C3G to raise awareness and understanding of this rare, chronic disease affecting the kidneys NEW HAVEN, [...]

BioCryst Announces Initiation of the APeX-S Long-Term Safety Trial of BCX7353 in Patients with Hereditary Angioedema

28/02/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today the dosing of the first patient in APeX-S, a long-term safety trial evaluating two dosage [...]

RadNet, Inc. Announces Date of its Fourth Quarter 2017 Financial Results Conference Call

28/02/2018 - 12:00

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Amarin Sponsors Multiple Scientific Presentations Scheduled for 2018 American College of Cardiology Annual Scientific Session & Expo

28/02/2018 - 11:00

BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]